Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V, HEPVIR working group of the European Society for translational antiviral research (ESAR)

Open source

DOI
10.1186/s12879-018-3161-2
Published
2018 Jun 1
Container
BMC infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-018-3161-2,
  title = {Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.},
  author = {Colagrossi L and Hermans LE and Salpini R and Di Carlo D and Pas SD and Alvarez M and Ben-Ari Z and Boland G and Bruzzone B and Coppola N and Seguin-Devaux C and Dyda T and Garcia F and Kaiser R and Köse S and Krarup H and Lazarevic I and Lunar MM and Maylin S and Micheli V and Mor O and Paraschiv S and Paraskevis D and Poljak M and Puchhammer-Stöckl E and Simon F and Stanojevic M and Stene-Johansen K and Tihic N and Trimoulet P and Verheyen J and Vince A and Lepej SZ and Weis N and Yalcinkaya T and Boucher CAB and Wensing AMJ and Perno CF and Svicher V and HEPVIR working group of the European Society for translational antiviral research (ESAR)},
  year = {2018},
  journal = {BMC infectious diseases},
  doi = {10.1186/s12879-018-3161-2},
  url = {https://doi.org/10.1186/s12879-018-3161-2}
}

RIS

TY  - JOUR
TI  - Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
AU  - Colagrossi L
AU  - Hermans LE
AU  - Salpini R
AU  - Di Carlo D
AU  - Pas SD
AU  - Alvarez M
AU  - Ben-Ari Z
AU  - Boland G
AU  - Bruzzone B
AU  - Coppola N
AU  - Seguin-Devaux C
AU  - Dyda T
AU  - Garcia F
AU  - Kaiser R
AU  - Köse S
AU  - Krarup H
AU  - Lazarevic I
AU  - Lunar MM
AU  - Maylin S
AU  - Micheli V
AU  - Mor O
AU  - Paraschiv S
AU  - Paraskevis D
AU  - Poljak M
AU  - Puchhammer-Stöckl E
AU  - Simon F
AU  - Stanojevic M
AU  - Stene-Johansen K
AU  - Tihic N
AU  - Trimoulet P
AU  - Verheyen J
AU  - Vince A
AU  - Lepej SZ
AU  - Weis N
AU  - Yalcinkaya T
AU  - Boucher CAB
AU  - Wensing AMJ
AU  - Perno CF
AU  - Svicher V
AU  - HEPVIR working group of the European Society for translational antiviral research (ESAR)
PY  - 2018
JO  - BMC infectious diseases
DO  - 10.1186/s12879-018-3161-2
UR  - https://doi.org/10.1186/s12879-018-3161-2
ER  -

APA

L, C., LE, H., R, S., D, D. C., SD, P., M, A., Z, B., G, B., B, B., N, C., C, S., T, D., F, G., R, K., S, K., H, K., I, L., MM, L., S, M., V, M., O, M., S, P., D, P., M, P., E, P., F, S., M, S., K, S., N, T., P, T., J, V., A, V., SZ, L., N, W., T, Y., CAB, B., AMJ, W., CF, P., V, S., & (ESAR), H. W. G. O. T. E. S. F. T. A. R. (2018). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.. BMC infectious diseases. https://doi.org/10.1186/s12879-018-3161-2

Source records